Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Cerecor Receives Fast Track Designation for CERC-301 for the Treatment of Major Depressive Disorder

VIEWS: 0 PAGES: 2

BALTIMORE--(BUSINESS WIRE)--Cerecor receives Fast Track designation for CERC-301, an oral adjunctive, (NR2B antagonist with the potential to be the first in a new class of rapidly acting antidepressants currently in Phase 2.

More Info
To top